Group 1: Humanoid Robots - The new humanoid robot "Xiao Bumi" by Songyan Power achieved impressive sales, with over 200 units sold within 3 hours of launch, priced at 9998 yuan, making it the first high-performance humanoid robot under 10,000 yuan [2] - The launch of "Xiao Bumi" aims to bring emotional value to users before humanoid robots fully enter the home service market, indicating strong market interest and potential for future household applications [2] Group 2: Medical Robotics - Xiamen University Affiliated Cardiovascular Hospital successfully completed the world's first cross-border remote robotic-assisted cardiac intervention surgery, demonstrating real-time collaboration between Chinese and French experts over a distance of over 10,000 kilometers [6][7] - The surgery utilized a robot system developed by Xiamen Hospital, showcasing its independent intellectual property and receiving high praise from Bordeaux University Hospital experts for its milestone significance in global medical cooperation [7] Group 3: Robotics Infrastructure - The humanoid robot pilot base and application promotion center in Hangzhou officially opened, with a total investment of nearly 200 million yuan and an area of over 15,000 square meters, aimed at addressing mass production challenges for humanoid robots [11] - The base integrates various functions, including indoor precision testing and outdoor scenario validation, and is part of the core of Hangzhou's Zhijiang Robot Industry Service Port, enhancing the city's innovation system in the robotics sector [11] Group 4: Advanced Robotics Technology - A research team from the University of North Carolina developed "DNA flower" micro-robots, which can rapidly fold and unfold in response to environmental changes, showing potential for targeted tumor treatment and environmental cleanup [13] - The technology is still in early testing stages but holds promise for future applications, including digital storage capabilities [13] Group 5: Vision Restoration Technology - The PRIMA artificial vision technology has enabled a 70-year-old woman, previously blind due to age-related macular degeneration, to regain functional central vision, with 84% of patients in clinical trials achieving similar results [16] - PRIMA consists of an implant and special glasses, representing a significant advancement in vision restoration, with ongoing regulatory processes in Europe and the FDA [16]
快讯|松延动力“小布米”3小时卖掉200台；全球首例跨国远程机器人心脏介入手术完成；杭州市人形机器人中试基地暨应用推广中心启用
机器人大讲堂·2025-10-27 03:56